Quidelortho Corp revenue increases to $846.10 million in quarter ended Apr 2, 2023 from previous quarter
By USInMinutes - May 06, 2023, 06:13 PM ET
Last Updated - Jul 18, 2023, 03:35 PM EDT
Key fundamental financials
profit of $48.80 million
Revenue of $846.10 million
earnings per share of $0.73
Current Reporting
Revenue
Net Income
Profit/Loss
Apr 2023
$846.10 million
$48.80 million
profit
Oct 2022
$783.80
$19.20
profit
Jul 2022
$613.40 million
$19.30 million
profit
Quidelortho Corp [QDEL] has reported $48.80 million profit for the fiscal quarter ending Apr 2, 2023 while the earnings for the same period were $0.73 per share.
Revenue for the quarter was $846.10 million.
The Sandiego, California (CA)-based company operating in the in vitro & in vivo diagnostic substances sector has total shareholders equity of $4,996.50 million.